Genetic diagnosis of Mendelian disorders via RNA sequencing.

Nat Commun 2017 06 12;8:15824. Epub 2017 Jun 12.

Institute of Human Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany.

Across a variety of Mendelian disorders, ∼50-75% of patients do not receive a genetic diagnosis by exome sequencing indicating disease-causing variants in non-coding regions. Although genome sequencing in principle reveals all genetic variants, their sizeable number and poorer annotation make prioritization challenging. Here, we demonstrate the power of transcriptome sequencing to molecularly diagnose 10% (5 of 48) of mitochondriopathy patients and identify candidate genes for the remainder. We find a median of one aberrantly expressed gene, five aberrant splicing events and six mono-allelically expressed rare variants in patient-derived fibroblasts and establish disease-causing roles for each kind. Private exons often arise from cryptic splice sites providing an important clue for variant prioritization. One such event is found in the complex I assembly factor TIMMDC1 establishing a novel disease-associated gene. In conclusion, our study expands the diagnostic tools for detecting non-exonic variants and provides examples of intronic loss-of-function variants with pathological relevance.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms15824DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499207PMC
June 2017
158 Reads
10.742 Impact Factor

Publication Analysis

Top Keywords

genetic diagnosis
8
mendelian disorders
8
variants
5
molecularly diagnose
4
sites providing
4
providing clue
4
sequencing molecularly
4
splice sites
4
cryptic splice
4
mitochondriopathy patients
4
10% mitochondriopathy
4
transcriptome sequencing
4
diagnose 10%
4
clue variant
4
event complex
4
annotation prioritization
4
complex assembly
4
poorer annotation
4
prioritization challenging
4
prioritization event
4

Similar Publications